Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples